Evidence map›Paper›PMID 35259693›Full record

ArticleEpidemics2022

Recalibrating the notion of modelling for policymaking during pandemics.

Yot Teerawattananon, Sarin Kc, Y-Ling Chi, Saudamini Dabak, Joseph Kazibwe, Hannah Clapham, Claudia Lopez Hernandez, Gabriel M Leung, Hamid Sharifi, Mahlet Habtemariam and 8 more

Open access · goldAbstract read
In one paragraph

Article in Epidemics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Impact of COVID-19 pandemic on HTAsiaLink network members.International journal of technology assessment in health care · 2024
    Article
  7. Article
  8. Article
  9. Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 11 countries.

Yot TeerawattananonHealth Intervention and Technology Assessment Program (HITAP), Department of Health, Ministry of Public Health, 6th Floor, 6th Building, Tiwanon Road, Nonthaburi 11000, Thailand; Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS), 12 Science Drive 2, #10-01, 117549, Singapore.
Sarin KcHealth Intervention and Technology Assessment Program (HITAP), Department of Health, Ministry of Public Health, 6th Floor, 6th Building, Tiwanon Road, Nonthaburi 11000, Thailand. Electronic address: sarin.k@hitap.net.
Y-Ling ChiCentre for Global Development Europe, Great Peter House, Abbey Gardens, Great College St, Westminster, London SW1P 3SE, UK.
Saudamini DabakHealth Intervention and Technology Assessment Program (HITAP), Department of Health, Ministry of Public Health, 6th Floor, 6th Building, Tiwanon Road, Nonthaburi 11000, Thailand.
Joseph KazibweDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London (ICL), Faculty of Medicine Building, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Hannah ClaphamSaw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS), 12 Science Drive 2, #10-01, 117549, Singapore.
Claudia Lopez HernandezMayor's Office City of Bogota, Bogota City Hall, 111711, Colombia.
Gabriel M LeungLi Ka Shing Faculty of Medicine (HKUMed), Hong Kong University, 21 Sassoon Rd, Pok Fu Lam, Hong Kong.
Hamid SharifiHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences (KMU), Kerman 7616911320, Iran.
Mahlet HabtemariamAfrica Centres for Disease Control and Prevention, African Union Commission, Roosevelt Streeet, Addis Ababa, Ethiopia.
Mark BlecherNational Treasury, 120 Plein Street, Cape Town, Republic of South Africa.
Sania NishtarPoverty Alleviation and Social Safety Division, Government of Pakistan, Cabinet Secretariat, 4th Floor, Evacuee Trust Complex, F-5/1, Islamabad, Pakistan.
Swarup SarkarIndian Council for Medical Research (ICMR), Government of India, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi 110029, India.
David WilsonBill and Melinda Gates Foundation (BMGF), 500 5th Ave N, Seattle, WA 98109, USA.
Kalipso ChalkidouDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London (ICL), Faculty of Medicine Building, St Mary's Campus, Norfolk Place, London W2 1PG, UK; The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland.
Marelize GorgensWorld Bank Group (WBG), 1818H Street, N.W., Washington, DC 20433, USA.
Raymond HutubessyWorld Health Organisation (WHO), Avenue Appia 20, 1211 Geneva, Switzerland.
Suwit WibulpolprasertHealth Intervention and Technology Assessment Program (HITAP), Department of Health, Ministry of Public Health, 6th Floor, 6th Building, Tiwanon Road, Nonthaburi 11000, Thailand; International Health Policy Program (IHPP), Ministry of Public Health, Tiwanon Rd., Nonthaburi 11000, Thailand.
Health Intervention and Technology Assessment Program · THNational University of Singapore · SGAfrica Centres for Disease Control and Prevention · ETBill & Melinda Gates Foundation · USGlobal Fund to Fight AIDS, Tuberculosis and Malaria · CHGovernment of Pakistan · PKImperial College London · GBIndian Council of Medical Research · INKerman University of Medical Sciences · IRMinistry of Public Health · THNational Treasury · ZAUniversity of Hong Kong · HKWorld Bank Group · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

COVID-19 disease models have aided policymakers in low-and middle-income countries (LMICs) with many critical decisions. Many challenges remain surrounding their use, from inappropriate model selection and adoption, inadequate and untimely reporting of evidence, to the lack of iterative stakeholder engagement in policy formulation and deliberation. These issues can contribute to the misuse of models and hinder effective policy implementation. Without guidance on how to address such challenges, the true potential of such models may not be realised. The COVID-19 Multi-Model Comparison Collaboration (CMCC) was formed to address this gap. CMCC is a global collaboration between decision-makers from LMICs, modellers and researchers, and development partners. To understand the limitations of existing COVID-19 disease models (primarily from high income countries) and how they could be adequately support decision-making in LMICs, a desk review of modelling experience during the COVID-19 and past disease outbreaks, two online surveys, and regular online consultations were held among the collaborators. Three key recommendations from CMCC include: A 'fitness-for-purpose' flowchart, a tool that concurrently walks policymakers (or their advisors) and modellers through a model selection and development process. The flowchart is organised around the following: policy aims, modelling feasibility, model implementation, model reporting commitment. Holmdahl and Buckee (2020) A 'reporting standards trajectory', which includes three gradually increasing standard of reports, 'minimum', 'acceptable', and 'ideal', and seeks collaboration from funders, modellers, and decision-makers to enhance the quality of reports over time and accountability of researchers. Malla et al. (2018) A framework for "collaborative modelling for effective policy implementation and evaluation" which extends the definition of stakeholders to funders, ground-level implementers, public, and other researchers, and outlines how each can contribute to modelling. We advocate for standardisation of modelling processes and adoption of country-owned model through iterative stakeholder participation and discuss how they can enhance trust, accountability, and public ownership to decisions.

Indexed as

COVID-19Health PolicyHumansPandemicsPolicy Making

Identifiers

PMID35259693
PMCPMC8889889
OpenAlexW4214836928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.